e-Therapeutics (LSE:ETX) Short-Term Capital Lease Obligation : £0.09 Mil (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Short-Term Capital Lease Obligation?

e-Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Jul. 2023 was £0.09 Mil.

e-Therapeutics's quarterly Short-Term Capital Lease Obligation declined from Jul. 2022 (£0.41 Mil) to Jan. 2023 (£0.30 Mil) and declined from Jan. 2023 (£0.30 Mil) to Jul. 2023 (£0.09 Mil).

e-Therapeutics's annual Short-Term Capital Lease Obligation increased from Jan. 2021 (£0.02 Mil) to Jan. 2022 (£0.39 Mil) but then declined from Jan. 2022 (£0.39 Mil) to Jan. 2023 (£0.30 Mil).

e-Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for e-Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Short-Term Capital Lease Obligation Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.05

0.02

0.39

0.30

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	0.39	0.41	0.30	0.09

e-Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

e-Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics (LSE:ETX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

ETXPF:USA 3AQ:Germany

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021